Onyx Biotec IPO subscription opens from Wednesday, November 13, 2024, and closes on Monday, November 18, 2024. It is a book-built issue of worth up to Rs 29.34 crores of equity shares. This upcoming IPO is an entirely fresh issue of 48.10 lakh equity shares.
Also Read | Mangal Compusolution IPO Detail: Open Date, Close Date, GMP, Price Band
Onyx Biotec IPO Price Band
Onyx Biotec IPO price band is Rs 58 to Rs 61 per share. The minimum investment required for retail investors is Rs 1,22,000 (61 x 2000 shares). However, for the HNI category, the minimum investment amount required is Rs 2,44,000 (61 x 4,000 shares).
Onyx Biotec IPO GMP
Currently, Onyx Biotec IPO GMP (grey market premium) is at Rs 0. It is expected that the listing price can same as the allotment price that is Rs 61. However, if the subscription is oversubscribed, then Onyx Biotec IPO GMP may go up.
Onyx Biotec Allotment Status
Onyx Biotec IPO Allotment status will be available on its registrar Mas Services Limited website on Tuesday, November 19, 2024. Once the subscription ends after the closing of IPO bidding. The allotment status of investors who applied for IPO will be available on the registrar's website.
Onyx Biotec Listing Date
Onyx Biotec IPO listing date is decided on November 21, 2024. The Listing will be on the NSE SME platform. Retail investors can sell the shares after 10 AM on the listing day.
Onyx Biotec IPO: Listing Date, Lot Size, Issue Size, Price Band
IPO Date |
November 13, 2024 to November 18, 2024 |
Listing
Date |
Thursday, November 21, 2024 |
Face
Value |
Rs 10 per share |
Price
Band |
Rs 58 to Rs 61 per share |
Lot
Size |
2000 Shares |
Total
Issue Size |
4,810,000 shares |
Fresh
Issue |
4,810,000 shares |
Issue
Type |
Book Built Issue IPO |
Listing
At |
NSE SME |
Share
holding pre issue |
13,322,200 |
Share
holding post issue |
18,132,200 |
Market
Maker portion |
244,000 shares |
Onyx Biotec IPO: About the Company
Onyx Biotec Limited, established in 2005, is a prominent pharmaceutical company based in Himachal Pradesh, India. Specializing in the production of parenteral products, it offers a range of sterile solutions, including polyethene ampoules. Onyx Biotec has received recognition for its commitment to quality and innovation in drug manufacturing. Its focus on meeting healthcare needs places the company in an important position to supply essential medications across the region. With its strategic location near Solan, its distribution capabilities are well enhanced to provide efficient service delivery. As an exact brand name that encourages trust in the pharmacy market, Onyx Biotec continues to further the development of products while upholding regulatory rigour at its best, thus contributing substantially towards the health sector of India.
Onyx Biotec IPO Objectives
The company plans to use the Net Proceeds from the issue to upgrade its existing manufacturing Unit I to produce large-volume parentals for intravenous use, establish a high-speed carton packaging line at manufacturing Unit II for dry powder injections, repay or prepay a portion of its loans, and for general corporate purposes.
Onyx Biotec IPO: Key Dates, Allotment, Listing Date
IPO
Open Date |
Wednesday, November 13, 2024 |
IPO Close Date |
Monday, November 18, 2024 |
Basis of Allotment |
Tuesday, November 19, 2024 |
Initiation of Refunds |
Wednesday, November 20, 2024 |
Credit of Shares to Demat |
Wednesday, November 20, 2024 |
Listing Date |
Thursday, November 21, 2024 |
Cut-off time for UPI mandate
confirmation |
5 PM on November 18, 2024 |
Onyx Biotec IPO Subscription Details, IPO Reservation
Onyx Biotec IPO subscription details will be available after the IPO opens on November 13, 2024. Not less than 35.04% of the net offer is reserved for the retail category, not more than 49.89% of the net offer is reserved for Qualified Intuitional Buyers, and not less than 15.07% of the net offer is reserved for the HNI category.
Onyx Biotec IPO Lot Size Details
Onyx Biotec IPO lot size is set at 2000 shares per lot. The minimum investment required for retail investors is Rs 1,22,000 (61 x 2000 shares). However, for the HNI category, the minimum investment amount required is Rs 2,44,000 (61 x 4000 shares).
Onyx Biotec IPO Promoter Holdings
Onyx Biotec IPO promoters are Kantilal Jethva and Bhavin Jethwa. The promoter's combined shareholdings before the IPO was 88.60%; however, post-IPO their shareholdings will decline
Onyx Biotec Limited Company Financials (Amt in Lakhs)
Period Ended |
31 May 2024 |
31 Mar 2024 |
31 Mar 2023 |
31 Mar 2022 |
Assets |
7,476.57 |
7,413.58 |
5,872.36 |
3,683.84 |
Revenue |
1,054.11 |
5,387.43 |
3,961.65 |
4,498.09 |
Profit After Tax |
130.77 |
303.16 |
184.46 |
335.29 |
Net Worth |
2,618.64 |
2,487.87 |
1,820.16 |
1,637.59 |
Reserves and Surplus |
1,286.42 |
1,155.65 |
1,230.00 |
1,047.43 |
Total Borrowing |
3,156.14 |
3,078.04 |
2,922.83 |
1,224.39 |
Lead manager and Registrar of Onyx Biotec IPO
The IPO is managed by Horizon Management Private Limited, which is the book-running lead manager for this public issue. The company has appointed Mas Services Limited as the registrar for this public issue.
How to apply to Onyx Biotec IPO
Interested investors who wants to apply to the Onyx Biotec IPO can directly apply from Bigul trading app or you can apply by visiting here. You can also check the details of other upcoming IPO on Bigul platform.
Onyx Biotec IPO Review
The IPO of Onyx Biotec Limited may get a positive response from the general public as the sentiment among the general public is good because of the company's strong market position in the pharmaceutical sector; it specializes in sterile water for injections and dry powder injections. With over 100 clients and ISO certifications for quality and environmental management, the company shows stability and growth potential.
Onyx Biotec IPO FAQs
1. What are the
core details available of the Onyx Biotec IPO?
Onyx Biotec IPO is a book-built issue worth
up to Rs 29.34 crores. This upcoming IPO is an entirely fresh issue of 48.10
lakh equity shares.
2. What is the
Onyx Biotec IPO open date and close date?
Onyx Biotec IPO subscription opens on
Wednesday, November 13 2024, and closes on Monday, November 18 2024.
3. What is Onyx
Biotec IPO GMP?
Currently, Onyx Biotec IPO GMP (grey market premium) is at Rs 0. It is expected that the listing price
can same as the allotment price that is Rs 61. However, if the subscription is
oversubscribed, then Onyx Biotec IPO GMP may go up.
4. How do you
check the IPO Allotment status?
Onyx Biotec IPO Allotment details are
available on its registrar Mas Services Limited website. Once the subscription
ends after the closing of IPO bidding. The allotment status of investors who
applied for IPO will be available on the registrar's website.
5. Who is the
registrar and lead managers for Onyx Biotec IPO?
The IPO is managed by Horizon Management Private Limited, which is the book-running lead manager for this public issue. The company has appointed Mas Services Limited as the registrar for this public issue.
Also Read:
- What is IPO?
- What is IPO GMP?
- Difference between
IPO and FPO For Beginners
- Difference between SME IPO and Mainline IPO?